Saisei Pharma plans clinical study of oral MAF in COVID-19 patients details were featured on some website. Please check the below URL.

[] [] [] []

[Temporary suspension of acceptance and delivery delays of mail items destined to various countries/territories]

Due to Covid-19 outbreaks, EMS has announced that they have suspended services to some countries from their available destinations. For customers who have placed orders before this notice, we will proceed with a refund. Please accept our apologies for the inconvenience.

As of April 24th, EMS has added more countries to suspend the service including USA. Please check the latest information and the list of affected countries from the link below.

FedEx Priority may be an alternative shipping option for some countries. If you wish to use FedEx Priority, please check that your country is on their list of delivery service and then add Option FedEx Priority to your cart.

EMS:Temporary suspension of acceptance and delivery delays of mail items destined to various countries/territories

Effective May 26. We have suspended all orders from China (excluding Hong Kong and Macau). Personally imported packages shipped to mainland China are being refused customs clearance due to strict regulations being implemented.

MAFカプセル ラベル変更・内容量変更のご案内

by Saisei Pharma

MAFカプセル ラベル変更・内容量変更のご案内


【初乳MAF】(ショニュウ マフ)から、

【MAF CAPUSULES】(マフ カプセル)へと変更されております。









上記二点の変更により、1粒当たりの重量が従来の0.277gから0.148gへと変更となりました。繰り返しのご案内となりますが重量は変更になりましたが、主成分の配合に変更はないため、重要な成分の量は全く変化しておりません 。

添加物を見直し、品質をより向上するための製品改良が、 今回の重量変更の主たる理由であることをご理解いただけると幸いです。